Wird geladen...
Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond
Metastatic breast cancer remains an incurable disease, and new therapies are needed. One major limitation of chemotherapy is the toxicity associated with higher dose exposure. Antibody–drug conjugates (ADCs) are a complex and evolving class of agents specifically designed with the objective of deliv...
Gespeichert in:
| Veröffentlicht in: | BioDrugs |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933915/ https://ncbi.nlm.nih.gov/pubmed/33666903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-021-00472-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|